Elisabeth McCarty Wood

The eREACH2 study evaluates a digital intervention for cancer genetic testing compared to traditional counseling, aiming to improve access and outcomes for at-risk patients.

This study describes a telegenetics program that collaborates with local providers to improve access to cancer genetic testing, showing high provider participation and willingness to collaborate.

eREACH evaluates digital alternatives to genetic counseling for metastatic cancer patients, finding non-inferiority in short-term outcomes for one GC visit or fully digital models.